940
Views
0
CrossRef citations to date
0
Altmetric
Review

Sporothrix Schenckii Complex And Sporotrichosis, An Emerging Health Problem

, , , , , , & show all
Pages 85-102 | Published online: 16 Dec 2010

Bibliography

  • Hektoen L , PerkinsCF: Refractory subcutaneous abscesses caused by Sporothrix schenckii.J. Exp. Med.5 , 77–89 (1900).
  • Mariat F : Adaptation de Ceratocystis a la vie parasitaire chez l‘animal. Etude de l‘aquisition d‘un pouvoir pathogéne comparable a celui de Sporothrix schenckii.Sabouraudia9 , 191–205 (1971).
  • Suzuki K , KawasakiM, IshizakiH: Analysis of restriction profiles of mitochondrial DNA from Sporothrix schenckii and related fungi.Mycopathologia103 , 147–151 (1988).
  • O‘Reilly LC , AltmanSA: Macrorestriction analysis of clinical and environmental isolates of Sporothrix schenckii.J. Clin. Microbiol.44 , 2547–2552 (2006).
  • de Beer ZW , HarringtonTC, VismerHF, WingfieldBD, WingfieldMJ: Phylogeny of the Ophiostoma stenoceras–Sporothrix schenckii complex.Mycologia95 , 434–441 (2003).
  • Zhang N , CastleburyLA, MillerANet al. : An overview of the systematics of the Sordariomycetes based on a four-gene phylogeny.Mycologia98 , 1076–1087 (2006).
  • Marimon R , GenéJ, CanoJ, TrillesL, Dos Santos Lazera M, Guarro J: Molecular phylogeny of Sporothrix schenckii. J. Clin. Microbiol.44 , 3251–3256 (2006).
  • Watanabe S , KawasakiM, MochizukiT, IshizakiH: RFLP analysis of the internal transcribed spacer regions of Sporothrix schenckii.Jpn. J. Med. Mycol.45 , 165–175 (2004).
  • de Meyer EM , deBeer W, SummerbellRCet al.: Taxonomy and phylogeny of new wood- and soil-inhabiting Sporothrix species in the Ophiostoma stenoceras–Sporothrix schenckii complex. Mycologia100 , 647–661 (2008).
  • Marimon R , CanoJ, GenéJ, SuttonD, KawasakiM, GuarroJ: Sporothrix brasiliensis, S. globosa, and S. mexicana. Three new Sporothrix species of clinical interest.J. Clin. Microbiol.45 , 3198–3206 (2007).
  • Marimon R , GenéJ, CanoJ, GuarroJ: Sporothrix luriei: a rare fungus from clinical origin.Med. Mycol.46 , 621–625 (2008).
  • Nicot J , MariatF: Caracteres morphologiques et position systématique de Sporothrix schenckii agent de la sporotrichose humaine.Mycopathol. Mycol. Appl.49 , 53–65 (1973).
  • Rodríguez del Valle N , RosarioM, Torres-BlasiniG: Effects of pH, temperature, aeration and carbon source on the development of the mycelia or yeast forms of Sporothrix schenckii from conidia.Mycopathologia82 , 83–88 (1983).
  • Resto S , Rodríguez del Valle N: Yeast cell cycle of Sporothrix schenckii. J. Med. Vet. Mycol.26 , 13–24 (1988).
  • Hiruma M , KawadaA, IshibashiA: Ultrastructure of asteroid bodies in sporotrichosis.Mycoses34 , 103–107 (1991).
  • Ghosh A , MaityPK, HemashettarBM, SharmaVK, ChakrabartiA: Physiological characters of Sporothrix schenckii isolates.Mycoses45 , 449–454 (2002).
  • Romero-Martínez R , WheelerM, Guerrero-PlataA, RicoG, Torres-GuerreroH: Biosynthesis and function of melanin in Sporothrix schenckii.Infect. Immun.68 , 3696–3703 (2000).
  • Morris-Jones R , YoungchimS, GomezBLet al. : Synthesis of melanin-like pigments by Sporothrix schenckiiin vitro and during mammalian infection.Infect. Immun.71 , 4026–4033 (2003).
  • Almeida-Paes R , FrasesS, FialhoMonteiro PC, Gutierrez-GalhardoMC, Zancopé-OliveiraRM, NosanchukJD: Growth conditions influence melanization of Brazilian clinical Sporothrix schenckii isolates.Microbes Infect.11 , 554–562 (2009).
  • Teixeira PAC , Alvesde Castro R, RodriguesLanzana FFet al. : L-DOPA accessibility in culture medium increases melanin expression and virulence of Sporothrix schenckii yeast cells.Med. Mycol.48 , 687–695 (2010).
  • Cooper CR , DixonDM, SalkinIF: Laboratory-acquired sporotrichosis.J. Med. Vet. Mycol.30 , 169–171 (1992).
  • Travassos LR , LloydKO: Sporothrix schenckii and related species of Ceratocystis.Microbiol. Rev.44 , 683–721 (1980).
  • Lloyd KO , BitoonMA: Isolation and purification of a peptido-rhamnomannan from the yeast form of Sporothrix schenckii. Structural and immunochemical studies.J. Immunol.107 , 663–671 (1971).
  • Mendonca L , GorinPAJ, LloydKO, TravassosLR: Polymorphism of Sporothrix schenckii surface polysaccharides as a function of morphological differentiation.Biochemistry15 , 2423–2431 (1976).
  • Lopes-Bezerra LM , SchubachA, CostaOR: Sporothrix schenckii and sporotrichosis.An. Acad. Bras. Cienc.78 , 293–308 (2006).
  • Gonzalez-Ochoa A , FigueroaES: Polisacáridos del Sporotrichum schenckii, Datos immunológicos. Intra-dermoreacción en el diagnóstico de la esporotricosis,Rev. Inst. Salubr. Enferm. Trop. Mexico City8 , 143–153 (1947).
  • Arenas G , TorielloC: Actividad inmunológica de antígenos miceliales-levaduriformes de diferentes fases de crecimiento de Sporothrix schenckii.Rev. Mex. Mic.2 , 131–138 (1986).
  • Rippon JW : Tratado de Micología Médica. Interamericana McGraw-Hill, México DF, MX351–380 (1990).
  • Bonifaz A : Micología Médica Básica. McGraw-Hill, Mexico City, Mexico,167–184 (2010).
  • Barros MBL , SchubachA, Francesconi-Do-ValleACet al. : Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases.Clin. Infect. Dis.38 , 529–535 (2004).
  • Durden FM , ElewskiB: Fungal infections in HIV patients.Semin. Cutan. Med. Surg.16 , 200–207 (1997).
  • Dixon DM , SalkinIF, DuncanRAet al. : Isolation and characterization of Sporothrix schenckii from clinical and environmental sources associated with the largest U.S. epidemic of sporotrichosis.J. Clin. Microbiol.29 , 1106–1113 (1991).
  • Gonzalez-Ochoa A : Contribuciones recientes al conocimiento de la esporotricosis.Gac. Med. Mex.95 , 463–474 (1965).
  • Barros MB , SchubachTM, Gutierrez-GalhardoMCet al. : Sporotrichosis: an emergent zoonosis in Rio de Janeiro.Mem. Inst. Oswaldo Cruz96 , 777–779 (2001).
  • Schubach TMP , SchubachA, OkamotoTet al. : Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998–2001).J. Am. Vet. Med. Assoc.224 , 1623–1629 (2004).
  • Schubach TMP , SchubachA, OkamotoTet al. : Canine sporotrichosis in Rio de Janeiro, Brazil, clinical presentation, laboratory diagnosis and therapeutic response in 44 cases (1998–2003).Med. Mycol.44 , 87–92 (2006).
  • Schubach A , BarrosMB, WankeB: Epidemic sporotrichosis.Curr. Opin. Infect. Dis.21 , 129–133 (2008).
  • Schubach A , deLima Barros MB, SchubachTMet al.: Primary conjunctival sporotrichosis: two cases from a zoonotic epidemic in Rio de Janeiro, Brazil.Cornea24 , 491–493 (2005).
  • Feeney KT , ArthurIH, WhittleAJ, AltmanSA, SpeersDJ: Outbreak of sporotrichosis, Western Australia.Emerg. Infect. Dis.13 , 1228–1231 (2007).
  • Baroni A , PallaM, NoveneMRet al. : Sporotrichosis: success of itraconazole treatment.Skin Med.6 , 41–44 (2007).
  • Criseo G , MalaraG, RomeoO, PuglisiGuerra A: Lymphocutaneous sporotrichosis in an immunocompetent patient: a case report from extreme southern Italy.Mycopathologia166 , 159–162 (2008).
  • Mesa-Arango AC , Reyes-MontesMR, Pérez-MejíaAet al.: Phenotyping and genotyping of Sporothrix schenckii isolates according to geographic origin and clinical form of sporotrichosis.J. Clin. Microbiol.40 , 3004–3011 (2002).
  • Dixon DM , DuncanRA, HurdNJ: Use of a mouse model to evaluate clinical and environmental isolates of Sporothrix spp. from the largest US epidemic of sporotrichosis.J. Clin. Microbiol.30 , 951–954 (1992).
  • Arrillaga-Moncrieff I , CapillaJ, MayayoEet al. : Different virulence levels of the species of Sporothrix in a murine model.Clin. Microbiol. Infect.15 , 651–655 (2009).
  • Oliveira MME , Almeida-PaesR, MedeirosMuniz M, LimaBarros MB, GutierrezGalhardo MC, Zancopé-OliveiraRM: Sporotrichosis caused by Sporothrix globosa in Rio de Janeiro, Brazil: case report.Mycopathologia169 , 359–363 (2010).
  • Rocha MM , DassinT, LiraR, LimaEL, SeveroLC, LonderoAT: Sporotrichosis in patient with AIDS: report of a case and review.Rev. Iberoam. Micol.18 , 133–136 (2001).
  • Hardmann S , StephensonI, JenkinsDR, WiselkaMJ, JohnsonEM: Disseminated Sporothrix schenckii in a patient with AIDS.J. Infect.51 , e73–e77 (2005).
  • Callens SF , KiteteleF, LukunPet al. : Pulmonary Sporothrix schenckii infection in a HIV positive child.J. Trop. Pediatr.52 , 144–146 (2006).
  • Suzuki K , KawasakiM, IshizakiH: Analysis of restriction profiles of mitochondrial DNA from Sporothrix schenckii and related fungi.Mycopathologia103 , 147–151 (1988).
  • Takeda Y , KawasakiM, IshizakiH: Phylogeny and molecular epidemiology of Sporothrix schenckii in Japan.Mycopathologia116 , 9–14 (1991).
  • Ishizaki H , KawasakiM, AokiM, MiyajiM, NishimuraK, Garcia Fernandez JA: Mitocondrial DNA analysis of Sporothrix schenckii in Costa Rica. J. Med. Vet. Mycol.34 , 71–73 (1996).
  • Ishizaki H , KawasakiM, AokiM, MatsumotoT, PadhyeAA, MendozaM, NegroniR: Mitochondrial DNA analysis of Sporothrix schenckii in North and South America.Mycopathologia142 , 115–118 (1998).
  • Ishizaki H , KawasakiM, AokiM, VismerH, MuirD: Mitochondrial DNA analysis of Sporothrix schenckii in South Africa and Australia.Med. Mycol.38 , 433–436 (2000).
  • Ishizaki H , KawasakiM, MochizukiT, JinXZ, KagawaS: Environmental isolates of in China Sporothrix schenckii.Jpn. J. Med. Mycol.43 , 257–260 (2002).
  • Ishizaki H , KawasakiM, AokiMet al. : Mitochondrial DNA analysis of Sporothrix schenckii from China, Korea and Spain.Jpn. J. Med. Mycol.45 , 23–25 (2004).
  • Lin J , KawasakiM, AokiM, IshizakiH, YouG, LiR: Mitochondrial DNA analysis of Sporothrix schenckii clinical isolates from China.Mycopathologia148 , 69–72 (1999).
  • Kawasaki M , ArenasR, ZaitzC, YamashitaJT, RubioC. Molecular epidemiology of Sporothrix schenckii in Mexico, Brazil and Spain. Presented at: 4th Congress of the International Society for Human and Animal Mycology. Buenos Aires, Argentina,2000.
  • Mora-Cabrera M , AlonsoRA, Ulloa-ArvizuR, Torres-GuerreroH: Analysis of restriction profiles of mitochondrial DNA from Sporothrix schenckii.Med. Mycol.39 , 439–344 (2001).
  • Arenas R , MillerD, Campos-MaciasP: Epidemiological data and molecular characterization (mtDNA) of Sporothrix schenckii in 13 cases from Mexico.Int. J. Dermatol.46 , 177–179 (2007).
  • Watanabe S , KawasakiM, MochizukiT, IshizakiH: RFLP analysis of the internal transcribed spacer regions of Sporothrix schenckii.Jpn. J. Med. Mycol.45 , 165–175 (2004).
  • Ishizaki H , KawasakiM, AnzawaKet al. : Mitochondrial DNA analysis of Sporothrix schenckii in India, Thailand, Brazil, Colombia, Guatemala and Mexico.Jpn. J. Med. Mycol.50 , 19–26 (2009).
  • Tateishi T , MurayamaSY, OtsukaF, YamaguchiH. Karyotiping by PFGE of clinical isolates of Sporothrix schenckii.FEMS Immunol. Med. Mic.13 , 147–154 (1996).
  • Sugita Y : Molecular analysis of DNA polymorphism of Sporothrix schenckii.Jpn. J. Med. Mycol.41 , 11–15 (2000).
  • Lee JB , LeeSC, WonHY: Analysis of random amplified polymorphic DNA (RAPD) for Sporothrix schenckii and related fungi.Korean J. Med. Mycol.5 , 113- (2000).
  • Reis RS , Almeida-PaesR, MunizMde M, TavaresPMet al.: Molecular characterization of Sporothrix schenckii isolates from humans and cats involved in the sporotrichosis epidemic in Rio de Janeiro, Brazil.Mem. Inst. Oswaldo Cruz104 , 769–74 (2009).
  • Neyra E , FonteynePA, SwinneD, FaucheF, BustamanteB, NolardN: Epidemiology of human sporotrichosis investigated by amplified fragment length polymorphism.J. Clin. Microbiol.43 , 1348–1352 (2005).
  • Madrid H , CanoJ, GenéJ, BonifazA, TorielloC, GuarroJ: Sporothrix globosa, a pathogenic fungus with widespread geographical distribution,Rev. Iberoam. Micol.26 , 218–222 (2009).
  • Gutierrez-Galhardo MC , Zancopé-OliveiraRM, FrancesconiDo Valle ACet al.: Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil.Med. Mycol.46 , 141–151 (2008).
  • Marimon R , SerenaC, GenéJ, CanoJ, GuarroJ: In vitro antifungal susceptibilities of five species of Sporothrix.Antimicrob. Agents Chemother.52 , 732–734 (2008).
  • Criseo G , RomeoO: Ribosomal DNA sequencing and phylogenetic analysis of environmental Sporothrix schenckii strains: comparison with clinical isolates.Mycopathologia169 , 351–358 (2010).
  • Hu S , ChungWH, HungSIet al. : Detection of Sporothrix schenckii in clinical samples by a nested PCR assay.J. Clin. Microbiol.41 , 1414–1418 (2003).
  • Xu TH , LinJP, GaoXH, WeiH, LiaoW, ChenHD: Identification of Sporothix schenckii of various mtDNA types by nested PCR assay.Med. Mycol.22 , 1–5 (2009).
  • Sandhu GS , KlineBC, StockmanL, RobertsGD: Molecular probes for diagnosis of fungal infections.J. Clin. Microbiol.33 , 2913–2919 (1995).
  • Kano R , NakamuraY, WatanabeS, TsujimotoH, HasegawaA: Identification of Sporothrix schenckii based on sequences of the chitin synthase 1 gene.Mycoses44 , 261–265 (2001).
  • Kanbe T , NatsumeL, GotoIet al. : Rapid and specific identification of Sporothrix schenckii by PCR targeting the DNA topoisomerase II gene.J. Dermatol. Sci.38 , 99–106 (2005).
  • Bates S , HughesHB, MunroCAet al. : Outer chain N-glycans are required for cell wall integrity and virulence of Candida albicans.J. Biol. Chem.281 , 90–98 (2006).
  • Figueiredo CC , LimaOC, CarvalhoLet al. : The in vitro interaction of Sporothrix schenckii with human endothelial cells is modulated by cytokines and involves endothelial surface molecules.Microb. Pathog.36 , 177–188 (2004).
  • Casadevall A , PirofskiLA: Host–pathogen interactions: redefining the basic concepts of virulences and pathogenicity.Infect. Immun.67 , 3703–3713 (1999).
  • Pirofski LA , CasadevallA: The meaning of microbial exposure, infection colonisation, and disease in clinical practice.Lancet Infect. Dis.2 , 628–632 (2002).
  • Previato JO , GorinPAJ, HaskinRH, TravassosLR: Soluble and insoluble glucans from different cell types of Sporothrix schenckii.Exp. Mycol.3 , 92– 105 (1979).
  • Lloyd KO , BitoonMA: Isolation and purification of a peptide-rhamnomannan from the yeast form of Sporothrix schenckii: structural and immunochemical studies.J. Immunol.107 , 663–671 (1971).
  • Nakamura Y : Purification and isolation of a biologically active peptide-rhamnogalactan from Sporothrix schenckii.J. Dermatol.3 , 25–29 (1976).
  • Lopes-Alves LM , Mendonca-PreviatoL, FournetB, DegrandP, PreviatoJ: O-glycosidically linked oligosaccharides from peptidorhamnomannans of Sporothrix schenckii.Glycoconj. J.9 , 75–81 (1992).
  • Lopes-Alves LM , TravassosLR, PreviatoJO, Mendonca-PreviatoL: Novel antigenic determinant from peptidorhamnomann of Sporothrix schenckii.Glycobiology4 , 281–284 (1994).
  • Travassos LR , GorinPA, LloydKO: Discrimination between Sporothrix schenckii and Ceratocystis stenoceras rhamnomannans by proton and carbon-13 magnetic resonance spectroscopy.Infect. Immun.9 , 674–680 (1974).
  • Gorin PA , HaskinsRH, TravassosLR, Mendoca-PreviatoL: Further studies on the rhamnomannans and acidic rhamnomannans of Sporothrix schenckii and Ceratocystis stenoceras.Carbohydr. Res.55 , 21–33 (1977).
  • Lima OC , LopesBezerra LM: Identification of a concanavalin A binding antigen of the cell surface of Sporothrix schenckii.J. Med. Vet. Mycol.35 , 167–172 (1997).
  • Scott EN , MuchmoreHG: Immunoblot analysis of antibody response to Sporothrix schenckii.J. Clin. Microbiol.27 , 300–304 (1989).
  • Nascimento RC , AlmeidaSR: Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis.Immun. Med. Microb.43 , 241–247 (2005).
  • Mendes-Giannini JS , TaylorML, BoucharaJBet al. : Pathogenesis II. Fungal responses to host responses: interaction of host cells with fungi.Med. Mycol.38(Suppl. 1) , 113–123 (2000).
  • WasyInka JA , MooreMM: Adhesion of Aspergillus species to extracellular matrix protein: evidence for involvement of negatively charged carbohydrates on the conidial surface.Infect. Immun.68 , 3377–3384 (2000).
  • Taylor ML , DuarteEscalante E, PérezA, ZentenoE, TorielloC: Histoplasma capsulatum yeast-cells attach and agglutinate human erythrocytes.Med. Mycol.42 , 287–292 (2004).
  • González A , GómezBL, DiezSet al., : Purification and partial characterization of a Paracoccidioides brasiliensis protein with capacity to bind to extracellular matrix proteins.Infect. Immun.73 , 2486–2495 (2005).
  • Nobile CJ , NettJE, AndesDR, MitchellAP: Function of Candida albicans adhesion Hwp1 in biofilm formation.Eukaryot. Cell5 , 1604–1610 (2006).
  • Li F , PalecekSP: Distinct domains of the Candida albicans adhesin Eap1p mediate cell–cell and cell–substrate interactions.Microbiology154 , 1193–1203 (2008).
  • López-Ribot JL , ChaffinWL: Binding of extracellular matrix component entactin to Candida albicans.Infect. Immun.62 , 4564–4571 (1994).
  • Klotz SA , SmithRL: Gelatin fragments block adherence of Candida albicans to extracellular matrix proteins.Microbiology141 , 2681–2684 (1995).
  • Hostetter MK : Adherence molecules in pathogenic fungi.Curr. Opin. Infect. Dis.9 , 141–145 (1996).
  • Hostetter MK : Integrin-like proteins in Candida spp. and other microorganisms.Fungal Genet. Biol.28 , 135–145 (1999).
  • Lima OC , FigueiredoCC, PereiraBASet al. : Adhesion of the human pathogen Sporothrix schenckii to several extracellular matrix proteins.Braz. J. Med. Biol. Res.32 , 651–657 (1999).
  • Lima OC , BoucharaJP, RenierGet al. : Immunofluorescence and flow cytometry analysis of fibronectin and laminin binding to Sporothrix schenckii yeast cells and conidia.Microb. Pathog.37 , 131–140 (2004).
  • Lima OC , FigueiredoCC, PreviatoJOet al. : Involvement of fungal cell wall components the adhesion of Sporothrix schenckii.Microb. Pathog.69 , 6874–80 (2001).
  • Ruiz-Baca E , TorielloC, PérezAet al., : Isolation and some properties of a glycoprotein of 70 kDa (Gp70) from the cell wall of Sporothrix schenckii involved in fungal adherence to dermal extracellular matrix.Med. Mycol.47 , 185–196 (2009).
  • Nascimento RC , EspíndolaNM, CastroRAet al., : Passive immunization with monoclonal antibody against a 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis.Eur. J. Immunol.38 , 3080–3089 (2008).
  • Walzer PD : Immunological features of Pneumocystis carinii infection in human.Clin. Diagn. Lab. Immunol.6 , 149–155 (1999).
  • Tronchin G , BoucharaJP, AnnaixVet al. : Fungal cell adhesion molecules in Candida albicans.Eur. J. Epidemiol.7 , 23–33 (1991).
  • Tronchin G , EsnaultK, RenierGet al. : Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia.Infect. Immun.65 , 9–15 (1997).
  • Teixeira PA , deCastro RA, NascimentoRCet al., : Cell surface expression of adhesins for fibronectin correlates with virulence in Sporothrix schenckii.Microbiology155 , 3730–3738 (2009).
  • Herscovics A , OrleanP: Glycoprotein biosynthesis in yeast.FASEB J.7 , 540–550 (1993).
  • Da Rosa D , GezueleE, CalegariL, GoñiF: Excretion–secretion products and proteases from live Sporothrix schenckii yeast phase: immunological detection and cleavage of human IgG.Rev. Inst. Med. Trop. Sao Paulo51 , 1–7 (2009).
  • Mora-Montes HM , BatesS, NeteaMGet al. : Endoplasmic reticulum α-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host–fungus interaction.Eukaryot. Cell6 , 2184–93 (2007).
  • Aravalli RN , HuS, WoodsJP, LokensgardJR: Histoplasma capsulatum yeast phase-specific protein Yps3p induces Toll-like receptor 2 signaling.J. Neuroinflamm.5 , 30 (2008).
  • Cambi A , NeteaMG, Mora-MontesHMet al. : Dendritic cell interaction with Candida albicans critically depends on N-linked mannan.J. Biol. Chem.283 , 20590–20599 (2008).
  • Netea MG , BrownGD, KullbergBJ, GowNA: An integrated model of the recognition of Candida albicans by the innate immune system.Nat. Rev. Microbiol.6 , 67–78 (2008).
  • Doering TL : How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.Annu. Rev. Microbiol.63 , 223–247 (2009).
  • Mora-Montes HM , Ponce-NoyolaP, Villagómez-CastroJC, GowNAR, Flores-CarreónA, López-RomeroE: Protein glycosylation in Candida.Future Microbiol.4 , 1167–1183 (2009).
  • Willger SD , ErnstJF, AlspaughJA, LengelerKB: Characterization of the PMT gene family in Cryptococcus neoformans.PLoS ONE4 , e6321 (2009).
  • McKenzie CG , KoserU, LewisLEet al. : Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages.Infect. Immun.78 , 1650–1658 (2010).
  • Mora-Montes HM , BatesS, NeteaMGet al. : A multifunctional mannosyltransferase family in Candida albicans determines cell wall mannan structure and host–fungus interactions.J. Biol. Chem.285 , 12087–12095 (2010).
  • Kornfeld R , KornfeldS: Assembly of asparagine-linked oligosaccharides.Annu. Rev. Biochem.54 , 631–664 (1985).
  • Herscovics A : Importance of glycosidases in mammalian glycoprotein biosynthesis.Biochim. Biophys. Acta1473 , 96–107 (1999).
  • Lussier M , SdicuAM, BusseyH: The KTR and MNN1 mannosyltransferase families of Saccharomyces cerevisiae.Biochim. Biophys. Acta1426 , 323–334 (1999).
  • Munro CA , BatesS, BuurmanETet al. : Mnt1p and Mnt2p of Candida albicans are partially redundant α-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence.J. Biol. Chem.280 , 1051–1060 (2005).
  • Mora-Montes HM , Robledo-OrtizCI, González-SánchezLC, López-EsparzaA, López-RomeroE, Flores-CarreónA: Purification and biochemical characterisation of endoplasmic reticulum α1,2-mannosidase from Sporothrix schenckii.Mem. Inst. Oswaldo Cruz105 , 79–85 (2010).
  • O‘Reilly MK , ZhangG, ImperialiB: In vitro evidence for the dual function of Alg2 and Alg11: essential mannosyltransferases in N-linked glycoprotein biosynthesis.Biochemistry45 , 9593–9603 (2006).
  • Absmanner B , SchmeiserV, KämpfM, LehleL: Biochemical characterization, membrane association and identification of amino acids essential for the function of Alg11 from Saccharomyces cerevisiae, an α1,2-mannosyltransferase catalysing two sequential glycosylation steps in the formation of the lipid-linked core oligosaccharide.Biochem. J.426 , 205–217 (2010).
  • Herscovics A , RomeroPA, TremblayLO: The specificity of the yeast and human class I ER α 1,2-mannosidases involved in ER quality control is not as strict previously reported.Glycobiology12 , 14G–15G (2002).
  • Mora-Montes HM , López-RomeroE, ZinkerS, Ponce-NoyolaP, Flores-CarreónA: Hydrolysis of Man9GlcNAc2 and Man8GlcNAc2 oligosaccharides by a purified α-mannosidase from Candida albicans.Glycobiology14 , 593–5988 (2004).
  • Mora-Montes HM , López-RomeroE, ZinkerS, Ponce-NoyolaP, Flores-CarreónA: Heterologous expression and biochemical characterization of an α1,2-mannosidase encoded by the Candida albicans MNS1 gene.Mem. Inst. Oswaldo Cruz103 , 724–30 (2008).
  • Avezov E , FrenkelZ, EhrlichM, HerscovicsA, LederkremerGZ: Endoplasmic reticulum (ER) mannosidase I is compartmentalized and required for N-glycan trimming to Man5-6GlcNAc2 in glycoprotein ER-associated degradation.Mol. Biol. Cell19 , 216–225 (2008).
  • Lengeler KB , TielkerD, ErnstJF: Protein-O-mannosyltransferases in virulence and development.Cell. Mol. Life Sci.65 , 528–544 (2008).
  • Timpel C , Strahl-BolsingerS, ZiegelbauerK, ErnstJF: Multiple functions of Pmt1p-mediated protein O-mannosylation in the fungal pathogen Candida albicans.J. Biol. Chem.273 , 20837–20846 (1998).
  • Prill SK , KlinkertB, TimpelC, GaleCA, SchroppelK, ErnstJF: PMT family of Candida albicans: five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance.Mol. Microbiol.55 , 546–560 (2005).
  • Ruiz-Baca E , Villagómez-CastroJC, Leal-MoralesCA, Sabanero-LópezM, Flores-CarreónA, López-RomeroE: Biosynthesis of glycoproteins in the human pathogenic fungus Sporothrix schenckii: synthesis of dolichol phosphate mannose and mannoproteins by membrane-bound and solubilized mannosyl transferases.Antonie Van Leeuwenhoek88 , 221–230 (2005).
  • Lussier M , SdicuAM, BussereauF, JacquetM, BusseyH: The Ktr1p, Ktr3p, and Kre2p/Mnt1p mannosyltransferases participate in the elaboration of yeast O- and N-linked carbohydrate chains.J. Biol. Chem.272 , 15527–15531 (1997).
  • Pinto MR , GorinPAJ, WaitR, MulloyB, Barreto-BergterE: Structures of the O-linked oligosaccharides of a complex glycoconjugate from Pseudallescheria boydii.Glycobiology15 , 895–904 (2005).
  • Goto M : Protein O-glycosylation in fungi: diverse structures and multiple functions.Biosci. Biotechnol. Biochem.71 , 1415–1427 (2007).
  • DiDomenico B : Novel antifungal drugs.Curr. Opin. Microbiol.2 , 509–515 (1999).
  • Kan VL , BennettJE: Efficacies of four antifungal agents in experimental murine sporotrichosis.Antimicrob. Agents Chemother.32 , 1619–1623 (1988).
  • Silveira CP , Torres-RodriguezJM, Alvarado-RamirezEet al. : MICS and minimun fungicidal concentrations of amphotericin B, itraconazole, posaconazole and terbinafine in Sporothrix schenckii.J. Med. Microbiol.58 , 1607–1610 (2009).
  • Milewski S , MigniniF, MicossiL, BorowskiE: Antihistoplasmal in vitro and in vivo effect of Lys-Nva-FMDP.Med. Mycol.36 , 177–180 (1998).
  • Ram AF , ArentshorstM, DamveldRA, vanKuykPA, KlisFM, vander Hondel CA: The cell wall stress response in Aspergillus niger involves increased expression of the glutamine:fructose-6-phosphate amidotransferase-encoding gene (gfaA) and increased deposition of chitin in the cell wall.Microbiology150 , 3315–3326 (2004).
  • Naderer T , WeeE, McConvilleMJ: Role of hexosamine biosynthesis in Leishmania growth and virulence.Mol. Microbiol.69 , 858–869 (2008).
  • Buse MG : Hexosamines, insulin resistance, and the complications of diabetes: current status.Am. J. Physiol. Endocrinol. Metab.290 , E1–E8 (2006).
  • Liu J , RichardBD, ChathamJC: Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.J. Mol. Cell Cardiol.42 , 177–185 (2007).
  • Chatham JC , NötLG, FülöpN, MarchaseRB: Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.Shock9 , 431–40 (2008).
  • Whelan WL , BallouCE: Sporulation in D-glucosamine auxotrophs of Saccharomyces cerevisiae: meiosis with defective ascospore wall formation.J. Bacteriol.124 , 1545–1557 (1975).
  • Milewski S : Glucosamine-6-phosphate synthase – the multi-facets enzyme.Biochim. Biophys. Acta1597: 173–192 (2002).
  • Wojciechowski M , MilewskiS, MazerskiJ, BorowskiE: Glucosamine-6-phosphate synthase, a novel target for antifungal agents. Molecular modelling studies in drug design.Acta Biochim. Pol.52 , 647–653 (2005).
  • Milewski S , GabrielI, OlchowyJ: Enzymes of UDP–GlcNAc biosynthesis in yeast.Yeast23 , 1–14 (2006).
  • Floquet N , MoulleronS, DaherR, MaigretB, BadetB, Badet-DenisotMA: Ammonia channeling in bacterial glucosamine-6-phophate synthase (Glms): molecular dynamics simulations and kinetic studies of protein mutants.FEBS Lett.581 , 2981–2987 (2007).
  • Durand P , Golinelli-PinpaneauB, MouilleronS, BadetB, Badet-DenisotMA: Highlights of glucosamine-6P synthase catalysis.Arch. Biochem. Biophys.474 , 302–317 (2008).
  • Richez C , BoetzelJ, FloquetNet al. : Expression and purification of active human internal His6-tagged L-glutamine:D-fructose-6-P amidotransferase I.Protein Expr. Purif.54 , 45–53 (2007).
  • Sachadyn P , JedrzejezakR, MilewskiS, KurJ, BorowskiE: Purification to homogeneity of Candida albicans glucosamine-6-phosphate synthase overexpressed in Escherichia coli.Protein Expr. Purif.19 , 343–349 (2000).
  • Milewski S , SmithRJ, BrownAJP, GoodayGW: Purification and characterization of glucosamine-6-P synthase from Saccharomyces cerevisiae. In: Advances in Chitin Science. Domard A, Jeuniaux J, Muzzarelli R, Roberts G (Eds). Jacques Andre Publishers, Lyon, France 96–101 (1996).
  • González-Ibarra J , MilewskiS, Villagómez-CastroJC, Cano-CancholaC, López-RomeroE: Sporothrix schenckii: purification and partial biochemical characterization of glucosamine-6-phosphate synthase, a potential antifungal target.Med. Mycol.48 , 110–121 (2010).
  • Milewski S , KuszczakD, JedrzejezakR: Oligomeric structure and regulation of Candida albicans glucosamine-6-phosphate synthase.J. Biol. Chem.274 , 4000–4008 (1999).
  • Kornfeld R : Studies on L-glutamine D-fructose-6-phosphate amidotransferase I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine.J. Biol. Chem.242 , 3135–3141 (1967).
  • Kikuchi H , TsuikiS: Glucosaminephosphate syntase of human liver.Biochim. Biophys. Acta422 , 241–246 (1976).
  • Etchebehere LC , Costa-MaiaMJ: Phosphorylation-dependent regulation of amidotransferase during the development of Blastocladiella emersonii.Arch. Biochem. Biophys.272 , 301–310 (1989).
  • Borgia PT : Roles of the arlA, tsE and bimG genes of Aspergillus nidulans in chitin synthesis.J. Bacteriol.174 , 384–389 (1992).
  • Janiak MA , HoffmannM, MilewskaJM, MilewskiS: Hydrophobic derivatives of 2-amino-2-deoxy-D-glucitol-6-phosphate: a new type of D-glucosamine-6-phosphate synthase inhibitors with antifungal action.Bioorg. Med. Chem.11 , 1653–1662 (2003).
  • Olchowy J , GabrielI, MilewskiS: Functional domains and interdomain communication in Candida albicans glucosamine-6-phosphate synthase.Biochem. J.404 , 121–130 (2007).
  • Kenig M and AbrahamP: Antimicrobial activities and antagonists of bacilysin and anticapsin.J. Gen. Microbiol.94 , 37–45 (1976).
  • Milewski S , ChmaraH, BorowskiE: Antibiotic tetaine a selective inhibitor of chitin and mannoprotein biosyntesis in Candida albicans.Arch. Microbiol.145 , 234–240 (1986).
  • Hull RL , ZraikaS, UdayasankarJet al. : Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro.Am. J. Physiol. Cell Physiol.293 , 1586–1593 (2007).
  • Rajapakse AG , MingXF, CarvasJM, YangZ: The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects.Am. J. Physiol. Heart Circ. Physiol.296 , H815-H822 (2009).
  • Janiak MA , MilewskiS: Mechanism of antifungal action of kanosamine.Med. Mycol.39 , 401–408 (2001).
  • Zgódka D , JedrzejczakR, MilewskiS, BoroskiE: Amide and ester derivatves of N3-(4-methoxyfumaroyl)-(S)-2,3-daminoprpanoic acid: the selective inhibitor of glucosaine-6-phosphate synthase.Bioorg. Med. Chem.9 , 931–938 (2001).
  • Melcer A , LackaI, GabrielI, WojciechowskiM, LiberekB, WisniewskiA, MilewskiS: Rational design of N-alkyl derivatives of 2-amino-2-deoxy-D-glucitol-6P as antifungal agents.Bioorg. Med. Chem. Lett.17 , 6602–6606 (2007).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.